Mesoblast Limited vs TKO Group Holdings Inc — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while TKO Group Holdings Inc trades at $194.36 (market cap $14.24B). The key difference: TKO Group Holdings Inc is far larger — about 6.4× Mesoblast Limited's market cap, and TKO Group Holdings Inc pays a 1.6% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | TKO | |
|---|---|---|
Market Cap | $2.21B | $14.24B |
Sector | Technology | Technology |
52-Week High | $20.96 | $224.96 |
52-Week Low | $12.88 | $176.49 |
Enterprise Value | $2.21B | $18.60B |
Dividend Yield | — | 1.6% |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →